190 related articles for article (PubMed ID: 31819043)
1. BRD4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST.
Mu J; Sun P; Ma Z; Sun P
Cell Death Dis; 2019 Dec; 10(12):935. PubMed ID: 31819043
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.
Hu F; Li H; Liu L; Xu F; Lai S; Luo X; Hu J; Yang X
Mol Cancer; 2018 Jul; 17(1):107. PubMed ID: 30060750
[TBL] [Abstract][Full Text] [Related]
3. LIX1 regulates YAP activity and controls gastrointestinal cancer cell plasticity.
Guérin A; Martire D; Trenquier E; Lesluyes T; Sagnol S; Pratlong M; Lefebvre E; Chibon F; de Santa Barbara P; Faure S
J Cell Mol Med; 2020 Aug; 24(16):9244-9254. PubMed ID: 32633461
[TBL] [Abstract][Full Text] [Related]
4. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis.
Gou Y; Li X; Li P; Zhang H; Xu T; Wang H; Wang B; Ma X; Jiang X; Zhang Z
Hum Reprod; 2019 Apr; 34(4):646-658. PubMed ID: 30838396
[TBL] [Abstract][Full Text] [Related]
6. A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma.
Li X; Xu Q; Wu Y; Li J; Tang D; Han L; Fan Q
Carcinogenesis; 2014 Jun; 35(6):1362-70. PubMed ID: 24531940
[TBL] [Abstract][Full Text] [Related]
7. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition.
Hemming ML; Lawlor MA; Andersen JL; Hagan T; Chipashvili O; Scott TG; Raut CP; Sicinska E; Armstrong SA; Demetri GD; Bradner JE
Cancer Res; 2019 Mar; 79(5):994-1009. PubMed ID: 30630822
[TBL] [Abstract][Full Text] [Related]
8. Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages.
Nakatsumi H; Matsumoto M; Nakayama KI
Cell Rep; 2017 Nov; 21(9):2471-2486. PubMed ID: 29186685
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages mediate gastrointestinal stromal tumor cell metastasis through CXCL2/CXCR2.
Cai H; Chen Y; Chen X; Sun W; Li Y
Cell Immunol; 2023 Feb; 384():104642. PubMed ID: 36577281
[TBL] [Abstract][Full Text] [Related]
10. HMGA1 Promotes Macrophage Recruitment via Activation of NF-
Chen J; Ji K; Gu L; Fang Y; Pan M; Tian S
J Immunol Res; 2022; 2022():4727198. PubMed ID: 35785026
[TBL] [Abstract][Full Text] [Related]
11. Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-κB-CCL2 signaling in lung cancer.
Zhou L; Jiang Y; Liu X; Li L; Yang X; Dong C; Liu X; Lin Y; Li Y; Yu J; He R; Huang S; Liu G; Zhang Y; Jeong LS; Hoffman RM; Jia L
Oncogene; 2019 Jul; 38(29):5792-5804. PubMed ID: 31243299
[TBL] [Abstract][Full Text] [Related]
12. FoxM1 is regulated by both HIF-1α and HIF-2α and contributes to gastrointestinal stromal tumor progression.
Bai C; Liu X; Qiu C; Zheng J
Gastric Cancer; 2019 Jan; 22(1):91-103. PubMed ID: 29948390
[TBL] [Abstract][Full Text] [Related]
13. RACK1 overexpression is linked to acquired imatinib resistance in gastrointestinal stromal tumor.
Gao X; Xue A; Fang Y; Shu P; Ling J; Hou Y; Shen K; Qin J; Sun Y; Qin X
Oncotarget; 2016 Mar; 7(12):14300-9. PubMed ID: 26893362
[TBL] [Abstract][Full Text] [Related]
14. CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling.
Ma MZ; Zhuang C; Yang XM; Zhang ZZ; Ma H; Zhang WM; You H; Qin W; Gu J; Yang S; Cao H; Zhang ZG
Neoplasia; 2014 Mar; 16(3):265-78, 278.e1-13. PubMed ID: 24726140
[TBL] [Abstract][Full Text] [Related]
15. Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors.
Lu X; Pang Y; Cao H; Liu X; Tu L; Shen Y; Jia X; Lee JC; Wang Y
Cancer Res; 2021 May; 81(9):2481-2494. PubMed ID: 33727226
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and pathologic analysis of imatinib-resistant gastrointestinal stromal tumor xenografts].
Zheng S; Wang XJ; Jia J; Pan YL; Tao DY; Lu HS; Huang KE
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):176-80. PubMed ID: 22800481
[TBL] [Abstract][Full Text] [Related]
17. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract][Full Text] [Related]
19. Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling.
Rego SL; Helms RS; Dréau D
Angiogenesis; 2014 Jul; 17(3):573-85. PubMed ID: 24197832
[TBL] [Abstract][Full Text] [Related]
20. Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.
Hembruff SL; Jokar I; Yang L; Cheng N
Neoplasia; 2010 May; 12(5):425-33. PubMed ID: 20454514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]